Synthesis of azolylalkylquinolines with cytotoxic activity

Journal of Heterocyclic Chemistry

Volumn 33, Issue 2, 1996, Pages 415-420

  Abel, Mark D ^a   Luu, Hiep T ^a   Micetich, Ronald G ^a   Nguyen, Dai Q ^a   Oreski, A Bernadette ^a   Tempest, Mark L ^a   Daneshtalab, Mohsen ^a  

^a NAEJA Pharmaceutical Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; N (4 QUINOLYL) 11 (1 METHYLPYRAZOL 5 YL)UNDECANAMIDE; QUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; SARCOMA;

EID: 0029975675     PISSN: 0022152X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jhet.5570330233     Document Type: Article

References (5)

1. M. D. Abel, C. M. Ha, H. T. Luu, R. G. Micetich, D. Q. Nguyen, M, Nukatsuka, A. B. Oreski, M. L. Tempest, and M. Daneshtalab, Drug Design Discov., in press (1996).
2. M. D. Abel, C. M. Ha, H. T. Luu, R, G. Micetich, D. Q. Nguyen, M. Nukatsuka, A. B. Oreski, M. L. Tempest, and M. Daneshtalab, Drug Design Discov., in press (1996).
3. M. D. Abel, R. G. Micetich, M. Nukatsuka, A. B. Oreski, M. L. Tempest, and M. Daneshtalab, Drug Design Discov., in press (1996).
4. L. Friedman and H. Shechter, J. Org Chem., 25, 877 (1960).
5. This work was presented, in part, at The Fifteenth International Congress of Heterocyclic Chemistry in Taipei, August 6-11, 1995.